Patients with inflammatory bowel disease (IBD) have an increased risk of thrombotic complications. Moreover, a hypercoagulable state has been hypothesized as a contributing factor in the pathogenesis of IBD. Recently, a growing amount of interest has focused on mild-to-moderate hyperhomocysteinemia as a risk factor for thromboembolic disease. We aimed to evaluate the prevalence of hyperhomocysteinemia in patients with IBD and to investigate the contribution of genetic defects in the enzymes involved in homocysteine (Hcy) metabolism and vitamin status in determining increased levels of plasma total Hcy (tHcy).
Original languageEnglish
Pages (from-to)2677-2682
Number of pages6
JournalAmerican Journal of Gastroenterology
Publication statusPublished - 2001


  • Homocysteine
  • Hyperhomocysteinemia
  • Inflammatory Bowel Diseases
  • Polymorphism, Genetic
  • Prevalence


Dive into the research topics of 'Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this